Andrew Leuchter - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
Neurobiology Biology, Radiology, Mental Health

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Corlier J, Wilson A, Hunter AM, Vince-Cruz N, Krantz D, Levitt J, Minzenberg MJ, Ginder N, Cook IA, Leuchter AF. Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder. Cerebral Cortex (New York, N.Y. : 1991). PMID 30953441 DOI: 10.1093/cercor/bhz035  0.6
2019 Hunter AM, Minzenberg MJ, Cook IA, Krantz DE, Levitt JG, Rotstein NM, Chawla SA, Leuchter AF. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. Brain and Behavior. e01275. PMID 30941915 DOI: 10.1002/brb3.1275  0.6
2019 McGough JJ, Sturm A, Cowen J, Tung K, Salgari GC, Leuchter AF, Cook IA, Sugar CA, Loo SK. Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30768393 DOI: 10.1016/j.jaac.2018.11.013  0.6
2019 Cook IA, Wilson AC, Corlier J, Leuchter AF. Brain Activity and Clinical Outcomes in Adults With Depression Treated With Synchronized Transcranial Magnetic Stimulation: An Exploratory Study. Neuromodulation : Journal of the International Neuromodulation Society. PMID 30637862 DOI: 10.1111/ner.12914  0.6
2018 Philip NS, Leuchter AF, Cook IA, Massaro J, Goethe JW, Carpenter LL. Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder. Depression and Anxiety. PMID 30480860 DOI: 10.1002/da.22862  0.6
2017 Hunter AM, Nghiem TX, Cook IA, Krantz DE, Minzenberg MJ, Leuchter AF. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder. Clinical Eeg and Neuroscience. 1550059417746212. PMID 29224411 DOI: 10.1177/1550059417746212  0.6
2017 Van Dyk K, Hunter AM, Ercoli L, Petersen L, Leuchter AF, Ganz PA. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography. Breast Cancer Research and Treatment. PMID 28707203 DOI: 10.1007/s10549-017-4390-6  0.6
2017 Leuchter MK, Donzis EJ, Cepeda C, Hunter AM, Estrada-Sánchez AM, Cook IA, Levine MS, Leuchter AF. Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development? Frontiers in Neurology. 8: 91. PMID 28424652 DOI: 10.3389/fneur.2017.00091  0.6
2017 Kobayashi B, Cook IA, Hunter AM, Minzenberg MJ, Krantz DE, Leuchter AF. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? International Review of Psychiatry (Abingdon, England). 1-17. PMID 28362541 DOI: 10.1080/09540261.2017.1297697  0.6
2016 Leuchter AF, Hunter AM, Jain FA, Tartter M, Crump C, Cook IA. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder. Journal of Psychiatric Research. 84: 174-183. PMID 27770740 DOI: 10.1016/j.jpsychires.2016.10.002  0.6
2016 Scanlon GC, Jain FA, Hunter AM, Cook IA, Leuchter AF. Neurophysiologic Correlates of Headache Pain in Subjects With Major Depressive Disorder. Clinical Eeg and Neuroscience. PMID 27000108 DOI: 10.1177/1550059416632411  0.6
2016 Cook IA, Abrams M, Leuchter AF. Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder. Neuromodulation : Journal of the International Neuromodulation Society. 19: 299-305. PMID 26818103 DOI: 10.1111/ner.12399  0.6
2015 Leuchter AF, Hunter AM, Tartter M, Cook IA. Authors' reply. The British Journal of Psychiatry : the Journal of Mental Science. 207: 561-2. PMID 26628700 DOI: 10.1192/bjp.207.6.561b  0.6
2015 Hunter AM, Cook IA, Tartter M, Sharma SK, Disse GD, Leuchter AF. Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology. PMID 26319158 DOI: 10.1007/s00213-015-4047-2  0.6
2015 Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, et al. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimulation. 8: 787-94. PMID 26143022 DOI: 10.1016/j.brs.2015.05.005  0.6
2015 Leuchter AF, Hunter AM, Tartter M, Cook IA. Author's reply: To PMID 25213159. The British Journal of Psychiatry : the Journal of Mental Science. 206: 435. PMID 25934309 DOI: 10.1192/bjp.206.5.435  0.6
2015 Jain FA, Hunter AM, Leuchter AF, Brooks JO. A role for profiles of patient-specific depression characteristics and socioeconomic factors in the prediction of antidepressant treatment outcome. The Journal of Clinical Psychiatry. 76: 327. PMID 25830451 DOI: 10.4088/JCP.14lr09483  0.6
2015 Leuchter AF, Hunter AM, Krantz DE, Cook IA. Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Annals of the New York Academy of Sciences. 1344: 78-91. PMID 25809789 DOI: 10.1111/nyas.12742  0.6
2015 McGough JJ, Loo SK, Sturm A, Cowen J, Leuchter AF, Cook IA. An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder. Brain Stimulation. 8: 299-304. PMID 25533244 DOI: 10.1016/j.brs.2014.11.013  0.6
2015 Caudill MM, Hunter AM, Cook IA, Leuchter AF. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder. Clinical Eeg and Neuroscience. 46: 277-84. PMID 25258429 DOI: 10.1177/1550059414532443  0.6
2014 Leuchter AF, Hunter AM, Krantz DE, Cook IA. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience. 16: 525-37. PMID 25733956  0.6
2014 Leuchter AF, Hunter AM, Tartter M, Cook IA. Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. The British Journal of Psychiatry : the Journal of Mental Science. 205: 443-9. PMID 25213159 DOI: 10.1192/bjp.bp.113.140343  0.6
2014 Hunter AM, Kwan L, Ercoli LM, Mills BK, Cook IA, Ganz PA, Leuchter AF. Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psycho-Oncology. 23: 713-5. PMID 24890579 DOI: 10.1002/pon.3487  0.6
2014 Jain FA, Cook IA, Leuchter AF, Hunter AM, Davydov DM, Ottaviani C, Tartter M, Crump C, Shapiro D. Heart rate variability and treatment outcome in major depression: a pilot study. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 93: 204-10. PMID 24769434 DOI: 10.1016/j.ijpsycho.2014.04.006  0.6
2014 Leuchter AF, McGough JJ, Korb AS, Hunter AM, Glaser PE, Deldar A, Durell TM, Cook IA. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. Journal of Psychiatric Research. 54: 11-8. PMID 24726639 DOI: 10.1016/j.jpsychires.2014.03.009  0.6
2014 Cook IA, Hunter AM, Korb AS, Leuchter AF. Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder? Journal of Psychiatric Research. 53: 69-75. PMID 24630467 DOI: 10.1016/j.jpsychires.2014.01.018  0.6
2014 Cook IA, Espinoza R, Leuchter AF. Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurgery Clinics of North America. 25: 103-16. PMID 24262903 DOI: 10.1016/j.nec.2013.10.002  0.6
2013 Hunter AM, Cook IA, Abrams M, Leuchter AF. Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? Medical Hypotheses. 81: 1004-11. PMID 24112999 DOI: 10.1016/j.mehy.2013.09.016  0.6
2013 Ercoli LM, Castellon SA, Hunter AM, Kwan L, Kahn-Mills BA, Cernin PA, Leuchter AF, Ganz PA. Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging and Behavior. 7: 543-53. PMID 23955490 DOI: 10.1007/s11682-013-9237-0  0.6
2013 Cook IA, Schrader LM, Degiorgio CM, Miller PR, Maremont ER, Leuchter AF. Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy & Behavior : E&B. 28: 221-6. PMID 23773978 DOI: 10.1016/j.yebeh.2013.05.008  0.6
2013 Hunter AM, Leuchter AF, Power RA, Muthén B, McGrath PJ, Lewis CM, Cook IA, Garriock HA, McGuffin P, Uher R, Hamilton SP. A genome-wide association study of a sustained pattern of antidepressant response. Journal of Psychiatric Research. 47: 1157-65. PMID 23726668 DOI: 10.1016/j.jpsychires.2013.05.002  0.6
2013 Hunter AM, Korb AS, Cook IA, Leuchter AF. Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? The Journal of Neuropsychiatry and Clinical Neurosciences. 25: 126-33. PMID 23686030 DOI: 10.1176/appi.neuropsych.11110330  0.6
2013 Leuchter AF, Cook IA, Jin Y, Phillips B. The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Frontiers in Human Neuroscience. 7: 37. PMID 23550274 DOI: 10.3389/fnhum.2013.00037  0.6
2013 Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. The Journal of Clinical Psychiatry. 74: 51-6. PMID 23419226 DOI: 10.4088/JCP.10m06813  0.6
2013 Jain FA, Hunter AM, Brooks JO, Leuchter AF. Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depression and Anxiety. 30: 624-30. PMID 23288666 DOI: 10.1002/da.22045  0.6
2012 Leuchter A, Cook IA, Hunter AM. Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'. Journal of Psychopharmacology (Oxford, England). 26: 1162-3; author reply. PMID 22807041 DOI: 10.1177/0269881111430732  0.6
2012 Hunter AM, Cook IA, Leuchter AF. Does prior antidepressant treatment of major depression impact brain function during current treatment? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 711-20. PMID 22445212 DOI: 10.1016/j.euroneuro.2012.02.005  0.6
2012 Leuchter AF, Cook IA, Hunter AM, Cai C, Horvath S. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. Plos One. 7: e32508. PMID 22384265 DOI: 10.1371/journal.pone.0032508  0.6
2012 Kerber KB, Wisniewski SR, Luther JF, Leuchter AF, D'Empaire I, Trivedi MH, Rush AJ. Effects of heart disease on depression treatment: results from the COMED study. General Hospital Psychiatry. 34: 24-34. PMID 22001552 DOI: 10.1016/j.genhosppsych.2011.08.018  0.6
2011 Hunter AM, Cook IA, Greenwald SD, Tran ML, Miyamoto KN, Leuchter AF. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 28: 478-82. PMID 21946361 DOI: 10.1097/WNP.0b013e318230da8a  0.6
2011 Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Research. 192: 188-94. PMID 21546222 DOI: 10.1016/j.pscychresns.2010.12.007  0.6
2011 Muthén B, Asparouhov T, Hunter AM, Leuchter AF. Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial. Psychological Methods. 16: 17-33. PMID 21381817 DOI: 10.1037/a0022634  0.6
2010 Hunter AM, Cook IA, Leuchter AF. Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. Journal of Clinical Psychopharmacology. 30: 748-51. PMID 21057245 DOI: 10.1097/JCP.0b013e3181faa474  0.6
2010 Leuchter AF, Cook IA, Hamilton SP, Narr KL, Toga A, Hunter AM, Faull K, Whitelegge J, Andrews AM, Loo J, Way B, Nelson SF, Horvath S, Lebowitz BD. Biomarkers to predict antidepressant response. Current Psychiatry Reports. 12: 553-62. PMID 20963521 DOI: 10.1007/s11920-010-0160-4  0.6
2010 Kobak KA, Leuchter A, DeBrota D, Engelhardt N, Williams JB, Cook IA, Leon AC, Alpert J. Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. Journal of Clinical Psychopharmacology. 30: 193-7. PMID 20520295 DOI: 10.1097/JCP.0b013e3181d20912  0.6
2010 Warden D, Trivedi MH, Wisniewski SR, Kurian B, Zisook S, Kornstein SG, Friedman ES, Miyahara S, Leuchter AF, Fava M, Rush AJ. Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. Journal of Clinical Psychopharmacology. 30: 259-66. PMID 20473060 DOI: 10.1097/JCP.0b013e3181dbfd04  0.6
2010 Farahbod H, Cook IA, Korb AS, Hunter AM, Leuchter AF. Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography. Clinical Eeg and Neuroscience. 41: 19-23. PMID 20307012  0.6
2010 Hunter AM, Muthén BO, Cook IA, Leuchter AF. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. Journal of Psychiatric Research. 44: 90-8. PMID 19631948 DOI: 10.1016/j.jpsychires.2009.06.006  0.6
2009 Leuchter AF, Cook IA, Hunter AM, Korb AS. A new paradigm for the prediction of antidepressant treatment response. Dialogues in Clinical Neuroscience. 11: 435-46. PMID 20135901  0.6
2009 Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Research. 174: 152-7. PMID 19853417 DOI: 10.1016/j.pscychresns.2009.04.011  0.6
2009 Kalechstein AD, De la Garza R, Newton TF, Green MF, Cook IA, Leuchter AF. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. The Journal of Neuropsychiatry and Clinical Neurosciences. 21: 254-8. PMID 19776303 DOI: 10.1176/appi.neuropsych.21.3.254  0.6
2009 Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Research. 169: 124-31. PMID 19712979 DOI: 10.1016/j.psychres.2009.06.004  0.6
2009 Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Research. 169: 132-8. PMID 19709754 DOI: 10.1016/j.psychres.2009.04.004  0.6
2009 Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. Journal of Clinical Psychopharmacology. 29: 372-7. PMID 19593178 DOI: 10.1097/JCP.0b013e3181ac4aaf  0.6
2009 Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 120: 1313-9. PMID 19539524 DOI: 10.1016/j.clinph.2009.05.008  0.6
2009 Leuchter AF, Cook IA, Hunter A, Korb A. Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clinical Eeg and Neuroscience. 40: 78-83. PMID 19534301  0.6
2009 Hunter AM, Leuchter AF, Cook IA, Abrams M, Siegman BE, Furst DE, Chappell AS. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Medicine (Malden, Mass.). 10: 730-8. PMID 19453962 DOI: 10.1111/j.1526-4637.2009.00614.x  0.6
2008 Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clinical Eeg and Neuroscience. 39: 175-81. PMID 19044214  0.6
2008 Korb AS, Cook IA, Hunter AM, Leuchter AF. Brain electrical source differences between depressed subjects and healthy controls. Brain Topography. 21: 138-46. PMID 18958615 DOI: 10.1007/s10548-008-0070-5  0.6
2008 Leuchter AF, Lesser IM, Trivedi MH, Rush AJ, Morris DW, Warden D, Fava M, Wisniewski SR, Luther JF, Perales M, Gaynes BN, Stewart JW. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. Journal of Psychiatric Practice. 14: 271-80. PMID 18832958 DOI: 10.1097/01.pra.0000336754.19566.65  0.6
2008 Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. The American Journal of Psychiatry. 165: 342-51. PMID 18172020 DOI: 10.1176/appi.ajp.2007.06111868  0.6
2007 Shapiro D, Cook IA, Davydov DM, Ottaviani C, Leuchter AF, Abrams M. Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evidence-Based Complementary and Alternative Medicine : Ecam. 4: 493-502. PMID 18227917 DOI: 10.1093/ecam/nel114  0.6
2007 Leuchter A, Levey GS. Need to strike balance with industry-academia rules. Nature. 449: 658. PMID 17928837 DOI: 10.1038/449658c  0.6
2007 Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Fava M, Rush AJ. Insured and non-insured depressed outpatients: how do they compare? Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 73-82. PMID 17612846 DOI: 10.1080/10401230701334671  0.6
2007 Hunter AM, Cook IA, Leuchter AF. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. The Psychiatric Clinics of North America. 30: 105-24. PMID 17362807 DOI: 10.1016/j.psc.2006.12.002  0.6
2007 Cook IA, Bookheimer SY, Mickes L, Leuchter AF, Kumar A. Aging and brain activation with working memory tasks: an fMRI study of connectivity. International Journal of Geriatric Psychiatry. 22: 332-42. PMID 17236244 DOI: 10.1002/gps.1678  0.6
2007 Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas. 56: 54-60. PMID 16835012 DOI: 10.1016/j.maturitas.2006.05.010  0.6
2006 Hunter AM, Leuchter AF, Morgan ML, Cook IA. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. The American Journal of Psychiatry. 163: 1426-32. PMID 16877657 DOI: 10.1176/appi.ajp.163.8.1426  0.6
2006 Venneman S, Leuchter A, Bartzokis G, Beckson M, Simon SL, Schaefer M, Rawson R, Newton T, Cook IA, Uijtdehaage S, Ling W. Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 208-16. PMID 16720798 DOI: 10.1176/jnp.2006.18.2.208  0.6
2006 Moses T, Leuchter AF, Cook I, Abrams M. Does the clinical course of depression determine improvement in symptoms and quality of life? The Journal of Nervous and Mental Disease. 194: 241-8. PMID 16614544 DOI: 10.1097/01.nmd.0000207358.15230.80  0.6
2005 Krell HV, Leuchter AF, Cook IA, Abrams M. Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics. 46: 379-84. PMID 16145181 DOI: 10.1176/appi.psy.46.5.379  0.6
2005 Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Petersen T, Stegman D, Rush AJ. Characteristics of insured and noninsured outpatients with depression in STAR(*)D. Psychiatric Services (Washington, D.C.). 56: 995-1004. PMID 16088018 DOI: 10.1176/appi.ps.56.8.995  0.6
2005 Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. Journal of Psychiatric Research. 39: 461-6. PMID 15992554 DOI: 10.1016/j.jpsychires.2004.12.002  0.6
2005 Morgan ML, Witte EA, Cook IA, Leuchter AF, Abrams M, Siegman B. Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology. 52: 71-6. PMID 15990459 DOI: 10.1159/000086608  0.6
2005 Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. The Journal of Clinical Psychiatry. 66: 774-80. PMID 15960574  0.6
2005 Hunter AM, Leuchter AF, Morgan ML, Cook IA, Abrams M, Siegman B, DeBrota DJ, Potter WZ. Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 792-9. PMID 15637637 DOI: 10.1038/sj.npp.1300652  0.6
2004 Krell HV, Leuchter AF, Morgan M, Cook IA, Abrams M. Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. The Journal of Clinical Psychiatry. 65: 1174-9. PMID 15367043 DOI: 10.4088/JCP.v65n0904  0.6
2004 Stubbeman WF, Leuchter AF, Cook IA, Shurman BD, Morgan M, Gunay I, Gonzalez S. Pretreatment neurophysiologic function and ECT response in depression. The Journal of Ect. 20: 142-4. PMID 15342997 DOI: 10.1097/00124509-200409000-00004  0.6
2004 Marie-Mitchell A, Leuchter AF, Chou CP, James Gauderman W, Azen SP. Predictors of improved mood over time in clinical trials for major depression. Psychiatry Research. 127: 73-84. PMID 15261707 DOI: 10.1016/j.psychres.2004.02.013  0.6
2004 Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology. 177: 15-22. PMID 15252704 DOI: 10.1007/s00213-004-1919-2  0.6
2004 Cook IA, Leuchter AF, Morgan ML, Dunkin JJ, Witte E, David S, Mickes L, O'Hara R, Simon S, Lufkin R, Abrams M, Rosenberg S. Longitudinal progression of subclinical structural brain disease in normal aging. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 12: 190-200. PMID 15010348 DOI: 10.1097/00019442-200403000-00010  0.6
2004 Newton TF, Kalechstein AD, Hardy DJ, Cook IA, Nestor L, Ling W, Leuchter AF. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 115: 194-8. PMID 14706488 DOI: 10.1016/S1388-2457(03)00314-6  0.6
2003 Newton TF, Cook IA, Kalechstein AD, Duran S, Monroy F, Ling W, Leuchter AF. Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 114: 410-5. PMID 12705421 DOI: 10.1016/S1388-2457(02)00409-1  0.6
2002 Cook IA, Leuchter AF, Morgan ML, Conlee EW, David S, Lufkin R, Babaie A, Dunkin JJ, O'Hara R, Simon S, Lightner A, Thomas S, Broumandi D, Badjatia N, Mickes L, et al. Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. Archives of Neurology. 59: 1612-20. PMID 12374500 DOI: 10.1001/archneur.59.10.1612  0.6
2002 Cook IA, Morgan ML, Dunkin JJ, David S, Witte E, Lufkin R, Abrams M, Rosenberg S, Leuchter AF. Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. International Journal of Geriatric Psychiatry. 17: 610-8. PMID 12112157 DOI: 10.1002/gps.644  0.6
2002 Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 120-31. PMID 12062912 DOI: 10.1016/S0893-133X(02)00294-4  0.6
2002 Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. The American Journal of Psychiatry. 159: 122-9. PMID 11772700 DOI: 10.1176/appi.ajp.159.1.122  0.6
1994 Leuchter A, Simon SL, Daly KA, Abrams M, Rosenberg-Thompson S, Dunkin JJ, Cook IA, Newton TF, Spar JE. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part II: Two-Year Follow-Up of Patients With Depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 2: 290-299. PMID 28530979 DOI: 10.1097/00019442-199402040-00004  0.6
1994 Leuchter A, Simon SL, Daly KA, Rosenberg-Thompson S, Abrams M, Dunkin JJ, Cook IA, Newton TF, Walter DO, Cummings JL. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part I: Cross-Sectional and Longitudinal Assessment of Patients With Dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 2: 200-209. PMID 28530933 DOI: 10.1097/00019442-199400230-00004  0.6
Show low-probability matches.